Clinical Edge Journal Scan

Agreement between modalities for imaging of finger joints in PsA patients


 

Key clinical point : There is favorable agreement between ultrasound (US) and magnetic resonance imaging (MRI) for detecting inflammatory changes in finger joints of patients with psoriatic arthritis (PsA). Additionally, there is a favorable agreement between US, radiography and MRI for detecting destructive changes.

Major finding : The absolute agreement between US and MRI was in the range of good-to-very good for detecting synovitis (85%-96%), flexor tenosynovitis (93%-98%), and extensor paratenonitis (95%-98%). Agreement between US, MRI and radiography was also good-to-very good for detecting erosions (96%-98%) and bone proliferations (71%-93%).

Study details : The data come from a study of 100 consecutive PsA patients who underwent clinical assessment and concomitant radiographic, US and MRI evaluations of the metacarpophalangeal, proximal interphalangeal and distal interphalangeal joints of one hand.

Disclosures: The study was supported by an investigator-initiated research grant sponsored by Johnson and Johnson. The authors declared no conflicts of interest.

Source: Polachek A et al. Rheumatology (Oxford). 2021 Mar 17. doi: 10.1093/rheumatology/keab272 .

Recommended Reading

FDA warning letters target OTC cannabidiol product claims for pain relief
MDedge Rheumatology
COVID-19 vaccination in RMD patients: Safety data “reassuring”
MDedge Rheumatology
Experts highlight recent breakthroughs in psoriatic arthritis
MDedge Rheumatology
Is pain linked to mortality risk in patients with psoriatic arthritis?
MDedge Rheumatology
PsA: Brodalumab demonstrates favorable efficacy in phase 3 trials
MDedge Rheumatology
Continuing ixekizumab superior to withdrawal in stable psoriatic arthritis
MDedge Rheumatology
Risk factors for progression from subclinical to clinical psoriatic arthritis
MDedge Rheumatology
Depression and anxiety linked to reduced probability of achieving sustained MDA in PsA
MDedge Rheumatology
Intravenous golimumab improves HRQoL and productivity in patients with active PsA
MDedge Rheumatology
Cognitive impairment is a manifestation of PsA
MDedge Rheumatology